2563 — Beijing Biostar Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual balance sheet for Beijing Biostar Pharmaceuticals, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	ARS	ARS
Standards:	HKAS	HKAS	HKAS	CAS
Status:	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	729	576	564	457
Net Total Accounts Receivable
Net Total Receivables	39	15.9	28.1	72.2
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	805	634	699	578
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	118	136	177	148
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	926	772	913	774
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	51.7	43.7	79.2	69.4
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	58.4	49.2	122	108
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	868	723	791	666
Total Liabilities & Shareholders' Equity	926	772	913	774
Total Common Shares Outstanding